Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
- Status
- COMPLETED
- Phase
- PHASE3
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
SORAVE - Sorafenib and Everolimus in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate SID 530 Compared to Taxotere
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen
- Status
- UNKNOWN
- Phase
- PHASE2